CD4 and rheumatoid arthritis: It has been proposed that the pathogenic mechanism of YKL-40 in RA initiates with its binding to HLA-DR4 peptide-binding motif promoting the mononuclear cells proliferation and HLA-DM plays a key role to presenting YKL-40 to CD4 + T cell.